Insights from analysts' 12-month price targets are revealed, presenting an average target of $4.62, a high estimate of $8.00, ...

We recently published a list of Top 10 Stocks to Buy According to 12 West Capital Management. In this article, we are going ...

RBC Capital analyst Conor McNamara maintained a Buy rating on Maravai Lifesciences Holdings (MRVI – Research Report) on March 21 and set a ...

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) shares gapped down before the market opened on Friday ...

In a report released on March 21, Brandon Couillard from Wells Fargo maintained a Buy rating on Maravai Lifesciences Holdings (MRVI – Research ...

Maravai LifeSciences (NASDAQ:MRVI – Free Report) had its price objective trimmed by UBS Group from $8.00 to $2.50 in a report ...

The stock market is in a bit of a tailspin of late as investors worry about the future of the economy. It can be a great idea ...

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Maravai LifeSciences Holdings, Inc. ("Maravai" or the "Company") (NASDAQ: MRVI) and reminds ...

Greetings. Welcome to Maravai LifeSciences fourth quarter 2024 results earnings call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal ...

Maravai LifeSciences Holdings, Inc.’s MRVI share price has surged by 10.86%, which has investors questioning if this is right time to sell.

Represents additional corporate income taxes at an assumed effective tax rate of approximately 24% applied to additional net loss attributable to Maravai LifeSciences Holdings, Inc. from the ...